SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Stayhealthy.com: Monitoring your wellness on the Web
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: george eberting who wrote (3746)5/5/2015 3:00:59 PM
From: rogerover  Read Replies (1) of 3785
 
George, to expand on what Coz wrote... the old public Avalon shares were converted to Stayhealthy shares at a price of .25 and a 1:8 ratio, so those of us who once held AVAL in effect paid $2.00/share by not accepting the .25 buyout price. (Many years ago, I realized that Rick McBride -- remember him? -- had the right idea.) If you were here in 1997, you must have had AVAL like Caly, Claudia, Mads and a few others of us.

There was also a Rule 504 offering in 1998 or 1999 where some people purchased shares privately at $2.00/share, which predated the Series A $1.30/share offering that Coz referred to. Series B was also sold at $1.30. Beginning a few years later, when the company was circling the drain after the Amerisource Bergen and Petters debacles, a lot of shares were sold at .25. There might have been some sold at .50 as well, I don't recall.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News